Biogen Idec CEO James Mullen - CEO pay report
James Mullen - Biogen Idec
Total Compensation: $8.9 million
Details: Mullen garnered $1.14 million in base salary, $1.94 million in incentives and $159,625 in other compensation. Most of Mullen's earnings this year came from $7.23 million in stock. Despie the big numbers, Mullen earned almost a third less in 2007 than he did in 2006, primairly due to Biogen Idec's failed bid to find a buyer for the company.
Biogen Idec News:
Biogen squares off against Icahn
Icahn aims for Biogen control
Biogen CEO: Pharma too wimpy to deal
Biogen shares deflate as it gives up on sale
Biogen Idec in play after Icahn makes his move
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets